So umgehen Sie die Opioidtoleranz

[1]  C. Zöllner,et al.  Induzieren Opioide Hyperalgesie? , 2010, Der Anaesthesist.

[2]  M. Zenz,et al.  Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen (LONTS) , 2009, Der Schmerz.

[3]  D. Fishbain,et al.  Do opioids induce hyperalgesia in humans? An evidence-based structured review. , 2009, Pain medicine.

[4]  D. Sessler,et al.  Remifentanil-induced Postoperative Hyperalgesia and Its Prevention with Small-dose Ketamine , 2005, Anesthesiology.

[5]  J. Jage.  Opioid tolerance and dependence — do they matter? , 2005, European journal of pain.

[6]  M. Irwin,et al.  Intraoperative Remifentanil Infusion Does Not Increase Postoperative Opioid Consumption Compared with 70% Nitrous Oxide , 2005, Anesthesiology.

[7]  Martin S Angst,et al.  Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal , 2003, Pain.

[8]  B. Bie,et al.  Presynaptic Mechanism for Anti-Analgesic and Anti-Hyperalgesic Actions of κ-Opioid Receptors , 2003, The Journal of Neuroscience.

[9]  E. Freye,et al.  [Development of opioid tolerance -- molecular mechanisms and clinical consequences]. , 2003, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[10]  Christopher J. Evans,et al.  Morphine Activates Opioid Receptors without Causing Their Rapid Internalization* , 1996, The Journal of Biological Chemistry.

[11]  L. Christrup,et al.  The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. , 1995, Life sciences.

[12]  Xiao-jun Xu,et al.  Cholecystokinin and morphine analgesia: variations on a theme. , 1994, Trends in pharmacological sciences.

[13]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Stanley J. Watson,et al.  Cloning and pharmacological characterization of a rat μ opioid receptor , 1993, Neuron.

[15]  G. Gebhart,et al.  Nitric oxide (NO) and nociceptive processing in the spinal cord , 1993, Pain.

[16]  M. Maze,et al.  Alpha‐2 Adrenoceptor Agonists: Defining the Role in Clinical Anesthesia , 1991, Anesthesiology.

[17]  T. Yaksh,et al.  Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. , 1989, The Journal of pharmacology and experimental therapeutics.